HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission.

AuthorsS Cherrier-De Wilde, K Rack, P Vannuffel, A Delannoy, A Hagemeijer
JournalLeukemia (Leukemia) Vol. 17 Issue 10 Pg. 2046-8 (Oct 2003) ISSN: 0887-6924 [Print] England
PMID14513056 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
Topics
  • Adult
  • Antineoplastic Agents (therapeutic use)
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Karyotyping
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy, genetics)
  • Male
  • Philadelphia Chromosome
  • Piperazines (therapeutic use)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (genetics)
  • Pyrimidines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: